1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Liver Diseases, Parasitic: new trials by email Literature Review of Liver Diseases, Parasitic trials Research Report on Liver Diseases, Parasitic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). Egaten (Triclabendazole) 250 mg tablets - Fascioliasis | Phase 4 | Completed | Novartis Pharmaceuticals | 301 | 2022-02-11 | 2026-11-06 |
Fascioliasis (1)
Digestive System Diseases (1) · Helminthiasis (1) · Infections (1) · Liver Diseases (1) · Parasitic Diseases (1) · Trematode Infections (1)
Triclabendazole (1)
Colombia (1) · Egypt (1) · Peru (1) · Turkey (Türkiye) (1) · Vietnam (1)